Orthogon Therapeutics
Canton · Biotechnology, Health Care, Information Technology · 50 employees
Orthogon Therapeutics is a privately held R&D company. Orthogon uses structure-based drug design and biophysics to successfully optimize drugs that bind selectively and safely neutralize target proteins that have been considered difficult to “drug”. The Company was founded by a veteran biotech entrepreneur and experienced drug discovery scientists with a mission to prolong and improve patient qual
Funding history
- Funding Round — $11.0M — Apr 2026
- Funding Round — $5.2M — Dec 2024
Recent signals
- Apr 17, 2026: Raised $11.0M in Funding Round
- Dec 10, 2024: Raised $5.2M in Funding Round
See plans & pricing → Track Orthogon Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.